“SAFETY, EFFICACY, AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED OR REFRACTORY CD30+ HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A SYSTEMATIC REVIEW”. REMUNOM, vol. 2, no. 02, Feb. 2026, pp. 1-23, https://doi.org/10.66104/hkgjcw62.